Dialysis Concentrates

with L-Ascorbic Acid (Vitamin C)

Verma-C Concentrates are specialized haemodialysis concentrates enhanced with L-Ascorbic Acid, offering an advanced approach to traditional dialysis treatment. These concentrates provide a host of critical advantages:

Oxidative Stress Management

These concentrates effectively control the oxidative stress index during dialysis, reducing the risk of oxidative damage to cells and tissues. This key feature helps preserve patient health during the rigorous process of dialysis.

Anti-Inflammatory Benefits

L-Ascorbic Acid, a potent antioxidant, plays a crucial role in protecting against chronic inflammation, a common issue in patients undergoing long-term dialysis. This protection helps mitigate associated health risks and improves patient comfort.

Stabilization of Vitamin C Levels: Maintaining optimal levels of Vitamin C during dialysis is essential for immune system support and overall health. Verma-C concentrates ensure that Vitamin C levels are kept consistent, which is crucial for preventing deficiencies that are often seen in renal patients.

Enhancement of Clinical Parameters

By improving critical clinical parameters, these concentrates contribute to the overall health and recovery process of patients, potentially reducing hospital stays and enhancing the quality of life.

Compliance with Pharmacopeia Standards

Adheres to the latest updates in the European Pharmacopoeia, ensuring the concentrates are manufactured to the highest quality standards.

Diverse Formulation Options

We provide a wide variety of concentrates compositions, allowing healthcare providers to choose or customize concentrates based on the unique needs and conditions of each patient. This flexibility ensures that all patients receive the most effective and personalized treatment possible.

Verma-C concentrates represent a significant advancement in dialysis treatment, combining the benefits of traditional methods with the powerful properties of L-Ascorbic Acid to deliver superior care and improved outcomes for renal disease patients.